Weight loss drug war heats up
Pfizer and Roche have released promising early stage results, but Novo Nordisk and Eli Lilly have a big head start.
Latest Posts
These stocks benefit from Canada’s immigration boom
Canada’s immigration policy offers opportunity for investors
Walt Disney’s turnaround takes shape
Shareholders in Walt Disney Co. (NYSE:DIS) had reason to feel better this year as a reorganization and restructuring plan seemedContinue Reading
Infrastructure ETFs offers hidden value
They offer slow growth and a steady stream of dividends.
TC Energy shareholders approve South Bow spinoff
South Bow to go public later this year and hold TC Energy’s pipeline assets.
Corby’s high dividend worth a toast
Expansion into ready-to-drink market a way to attract younger customers.
Big moats surround Microsoft, Nvidia
Both are at the heart of artificial intelligence developments.
The advantage of economic moats
Often intangible things, moats keep customers close and protect the business.
Patience pays off for Hydro One investors
Its shares have doubled since the 2018 selloff when Ontario’s Ford government fired its board.
Medtech finds AI applications
Artificial intelligence is making its mark in medical technology applications.
Adam Mayers 
You must be logged in to post a comment.